Cargando…
Correction to: Design of a Randomized, Placebo-Controlled, Phase 3 Trial of Tofersen Initiated in Clinically Presymptomatic SOD1 Variant Carriers: the ATLAS Study
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9606151/ https://www.ncbi.nlm.nih.gov/pubmed/36175782 http://dx.doi.org/10.1007/s13311-022-01286-9 |
| _version_ | 1784818235015692288 |
|---|---|
| author | Benatar, Michael Wuu, Joanne Andersen, Peter M. Bucelli, Robert C. Andrews, Jinsy A. Otto, Markus Farahany, Nita A. Harrington, Elizabeth A. Chen, Weiping Mitchell, Adele A. Ferguson, Toby Chew, Sheena Gedney, Liz Oakley, Sue Heo, Jeong Chary, Sowmya Fanning, Laura Graham, Danielle Sun, Peng Liu, Yingying Wong, Janice Fradette, Stephanie |
| author_facet | Benatar, Michael Wuu, Joanne Andersen, Peter M. Bucelli, Robert C. Andrews, Jinsy A. Otto, Markus Farahany, Nita A. Harrington, Elizabeth A. Chen, Weiping Mitchell, Adele A. Ferguson, Toby Chew, Sheena Gedney, Liz Oakley, Sue Heo, Jeong Chary, Sowmya Fanning, Laura Graham, Danielle Sun, Peng Liu, Yingying Wong, Janice Fradette, Stephanie |
| author_sort | Benatar, Michael |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9606151 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Springer International Publishing |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-96061512022-11-29 Correction to: Design of a Randomized, Placebo-Controlled, Phase 3 Trial of Tofersen Initiated in Clinically Presymptomatic SOD1 Variant Carriers: the ATLAS Study Benatar, Michael Wuu, Joanne Andersen, Peter M. Bucelli, Robert C. Andrews, Jinsy A. Otto, Markus Farahany, Nita A. Harrington, Elizabeth A. Chen, Weiping Mitchell, Adele A. Ferguson, Toby Chew, Sheena Gedney, Liz Oakley, Sue Heo, Jeong Chary, Sowmya Fanning, Laura Graham, Danielle Sun, Peng Liu, Yingying Wong, Janice Fradette, Stephanie Neurotherapeutics Correction Springer International Publishing 2022-09-29 2022-09 /pmc/articles/PMC9606151/ /pubmed/36175782 http://dx.doi.org/10.1007/s13311-022-01286-9 Text en © The American Society for Experimental Neurotherapeutics, Inc. 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Correction Benatar, Michael Wuu, Joanne Andersen, Peter M. Bucelli, Robert C. Andrews, Jinsy A. Otto, Markus Farahany, Nita A. Harrington, Elizabeth A. Chen, Weiping Mitchell, Adele A. Ferguson, Toby Chew, Sheena Gedney, Liz Oakley, Sue Heo, Jeong Chary, Sowmya Fanning, Laura Graham, Danielle Sun, Peng Liu, Yingying Wong, Janice Fradette, Stephanie Correction to: Design of a Randomized, Placebo-Controlled, Phase 3 Trial of Tofersen Initiated in Clinically Presymptomatic SOD1 Variant Carriers: the ATLAS Study |
| title | Correction to: Design of a Randomized, Placebo-Controlled, Phase 3 Trial of Tofersen Initiated in Clinically Presymptomatic SOD1 Variant Carriers: the ATLAS Study |
| title_full | Correction to: Design of a Randomized, Placebo-Controlled, Phase 3 Trial of Tofersen Initiated in Clinically Presymptomatic SOD1 Variant Carriers: the ATLAS Study |
| title_fullStr | Correction to: Design of a Randomized, Placebo-Controlled, Phase 3 Trial of Tofersen Initiated in Clinically Presymptomatic SOD1 Variant Carriers: the ATLAS Study |
| title_full_unstemmed | Correction to: Design of a Randomized, Placebo-Controlled, Phase 3 Trial of Tofersen Initiated in Clinically Presymptomatic SOD1 Variant Carriers: the ATLAS Study |
| title_short | Correction to: Design of a Randomized, Placebo-Controlled, Phase 3 Trial of Tofersen Initiated in Clinically Presymptomatic SOD1 Variant Carriers: the ATLAS Study |
| title_sort | correction to: design of a randomized, placebo-controlled, phase 3 trial of tofersen initiated in clinically presymptomatic sod1 variant carriers: the atlas study |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9606151/ https://www.ncbi.nlm.nih.gov/pubmed/36175782 http://dx.doi.org/10.1007/s13311-022-01286-9 |
| work_keys_str_mv | AT benatarmichael correctiontodesignofarandomizedplacebocontrolledphase3trialoftoferseninitiatedinclinicallypresymptomaticsod1variantcarrierstheatlasstudy AT wuujoanne correctiontodesignofarandomizedplacebocontrolledphase3trialoftoferseninitiatedinclinicallypresymptomaticsod1variantcarrierstheatlasstudy AT andersenpeterm correctiontodesignofarandomizedplacebocontrolledphase3trialoftoferseninitiatedinclinicallypresymptomaticsod1variantcarrierstheatlasstudy AT bucellirobertc correctiontodesignofarandomizedplacebocontrolledphase3trialoftoferseninitiatedinclinicallypresymptomaticsod1variantcarrierstheatlasstudy AT andrewsjinsya correctiontodesignofarandomizedplacebocontrolledphase3trialoftoferseninitiatedinclinicallypresymptomaticsod1variantcarrierstheatlasstudy AT ottomarkus correctiontodesignofarandomizedplacebocontrolledphase3trialoftoferseninitiatedinclinicallypresymptomaticsod1variantcarrierstheatlasstudy AT farahanynitaa correctiontodesignofarandomizedplacebocontrolledphase3trialoftoferseninitiatedinclinicallypresymptomaticsod1variantcarrierstheatlasstudy AT harringtonelizabetha correctiontodesignofarandomizedplacebocontrolledphase3trialoftoferseninitiatedinclinicallypresymptomaticsod1variantcarrierstheatlasstudy AT chenweiping correctiontodesignofarandomizedplacebocontrolledphase3trialoftoferseninitiatedinclinicallypresymptomaticsod1variantcarrierstheatlasstudy AT mitchelladelea correctiontodesignofarandomizedplacebocontrolledphase3trialoftoferseninitiatedinclinicallypresymptomaticsod1variantcarrierstheatlasstudy AT fergusontoby correctiontodesignofarandomizedplacebocontrolledphase3trialoftoferseninitiatedinclinicallypresymptomaticsod1variantcarrierstheatlasstudy AT chewsheena correctiontodesignofarandomizedplacebocontrolledphase3trialoftoferseninitiatedinclinicallypresymptomaticsod1variantcarrierstheatlasstudy AT gedneyliz correctiontodesignofarandomizedplacebocontrolledphase3trialoftoferseninitiatedinclinicallypresymptomaticsod1variantcarrierstheatlasstudy AT oakleysue correctiontodesignofarandomizedplacebocontrolledphase3trialoftoferseninitiatedinclinicallypresymptomaticsod1variantcarrierstheatlasstudy AT heojeong correctiontodesignofarandomizedplacebocontrolledphase3trialoftoferseninitiatedinclinicallypresymptomaticsod1variantcarrierstheatlasstudy AT charysowmya correctiontodesignofarandomizedplacebocontrolledphase3trialoftoferseninitiatedinclinicallypresymptomaticsod1variantcarrierstheatlasstudy AT fanninglaura correctiontodesignofarandomizedplacebocontrolledphase3trialoftoferseninitiatedinclinicallypresymptomaticsod1variantcarrierstheatlasstudy AT grahamdanielle correctiontodesignofarandomizedplacebocontrolledphase3trialoftoferseninitiatedinclinicallypresymptomaticsod1variantcarrierstheatlasstudy AT sunpeng correctiontodesignofarandomizedplacebocontrolledphase3trialoftoferseninitiatedinclinicallypresymptomaticsod1variantcarrierstheatlasstudy AT liuyingying correctiontodesignofarandomizedplacebocontrolledphase3trialoftoferseninitiatedinclinicallypresymptomaticsod1variantcarrierstheatlasstudy AT wongjanice correctiontodesignofarandomizedplacebocontrolledphase3trialoftoferseninitiatedinclinicallypresymptomaticsod1variantcarrierstheatlasstudy AT fradettestephanie correctiontodesignofarandomizedplacebocontrolledphase3trialoftoferseninitiatedinclinicallypresymptomaticsod1variantcarrierstheatlasstudy |